DUBLIN--(BUSINESS WIRE)--The "Biosensors - A Global Market Overview" report has been added to Research and Markets' offering.
Global Biosensors market is expected to record a robust CAGR of about 9% during the 2017-2022 analysis period and is projected to touch US$25.9 billion by 2022 from an estimated US$16.9 billion in 2017.
Electrochemical estimated the largest global Biosensors market by technology with 2017 market stood at US$12 billion while Optical segment is expected the fastest growing Biosensor market worldwide with a CAGR of 10.5% over the same period.
Point of Care Testing is expected to remain the largest application area for Biosensors reaching a projected US$11.5 billion by 2022 growing at a CAGR of 8.1% between 2017 and 2022. In regional markets, Asia Pacific is expected the fastest growing market witnessing a CAGR of 11.4% for the aforementioned period whereas the North American market is estimated the largest end-user for Biosensors.
Key Business Trends
- Abbott's FreeStyle Libre Glucose Monitoring System Reimbursement in Japan
- Nanomedical Diagnostics' New NHS Agile Biosensor Chip for Use on Agile R100 Label-free Personal Assay System
- Abbott and Bigfoot Enter into Collaboration to Develop Diabetes Technologies
- New NTA Biosensor Chip Launched for use with Label-free Agile R100 Assay System
- Abbott to Expand its FreeStyle Libre Flash Glucose Monitoring System Coverage in Canada
- CE Mark for Abbott's TactiCath Contact Force Ablation Catheter
- Release of Fully Automated Solution for Cell Culture Sampling and Complete Analysis for Bench-Scale Bioreactor Cultures
- Nanomedical Diagnostics' AGILE R100 Graphene Biosensor Received Patent from USPTO
- Aerialtronics Joined Forces with RAE Systems BeNeLux for Developing the Altura Zenith ATX8 UAS
- BD's First Step in the Fight against Antimicrobial Resistance
- CardioMEMS HF System from Abbott Aid in Heart Failure Hospitalizations
- Nanomedical Diagnostics and Rogue Valley Microdevices Partnered to Deliver AGILE R100 Graphene Biosensor
- FLEXcon and Polestar Join Forces
- Finesse Solutions Acquired by Thermo Fisher Scientific
- PathSensors and USDA's Agricultural Research Service team to Develop Bio Sensor Technology for Citrus Greening Disease
- Cepheid Became an Indirect Wholly Owned Subsidiary of Danaher
- PathSensors, Inc Develops Universal BioSensor Technology
- PathSensors Introduces New High Speed Diagnostic Plant Pathogen Assays
- Smith Detection Enhances IONSCAN 600 Detector Capabilities
- MBiotech Acquired by Integrated DNA Technologies
- Biosensors International Enters into Distribution Agreement with CORDIS
- BioProfile FLEX2, the Next Addition to the BioProfile Line of Cell Culture Chemistry Analyzers
- Affymetrix Acquired by Thermo Fisher Scientific
- LifeScan Launches Onetouch Verio Flex Blood Glucose Monitoring System
- Animas Vibe Insulation Pump and Continuous Glucose Monitoring System Received FDA Approval for Diabetes Management in Children Ages Two and Older
- New Drger Tcore Sensor for Non-Invasive and Accurate Measurement of Body's Core Temperature
- Nanomedical Diagnostics, Inc. Launched to Supply Monitoring and Diagnostic Platforms
- QIAGEN, the First New Entrant in the US Market for STR Test Kits
- New Exotic Gas Sensors are Now Available for Honeywell's QRAE 3 Gas Detector
- LifeScan Launches the New OneTouch Verio Sync Meter
Key Market Trends
- Technological Advancements in Point-of-Care Testing Further Promotes Growth of Biosensors
- Glucose Monitoring in Diabetes Worldwide Fueling the Growth of Biosensor Market
- Growing Emergence of Biosensors in Environmental Application
- Safety & Bio-Defense - The Emerging Field of Biosensors
- Optical Biosensors Leads the Growth of Biosensors Industry Driven by Emergence of New Technologies
Key Topics Covered:
Part A: Global Market Perspective
1. Introduction
2. Key Market Trends
3. Biosensors Research & Developments Activities
4. Key Global Players
5. Key Business & Product Trends
6. Global Market Overview
Part B: Regional Market Perspective
Regional Market Overview
1. North America
2. Europe
3. Asia Pacific
4. South America
5. Rest of World
Part C: Guide to the Industry
Part D: Annexure
Companies Mentioned
- 3M Company
- ABTECH Scientific, Inc.
- ACON Laboratories, Inc.
- Abbott Diabetes Care, Inc.
- Abbott Laboratories, Inc.
- Abbott Point of Care, Inc.
- Acon Laboratories, Inc.
- Affinity Biosensors, Llc
- Bayer AG
- Beckman Coulter, Inc.
- Becton, Dickinson and Company
- Bio-Rad Laboratories, Inc.
- Biomerica, Inc.
- Biosensor Applications Sweden AB
- Biosensors International Group, Ltd.
- Biosensors, Inc.
- EMD Millipore Corporation
- Ercon Inc.
- GE Healthcare Ltd.
- Medtronic, Inc.
- Nanomedical Diagnostics, Inc.
- Neuro-Kinesis Corporation
- Nova Biomedical Corporation
- Qiagen N.V.
- RAE Systems, Inc.
- Radiometer America, Inc.
- Roche Diagnostics Corporation
- SDIX, LLC (formerly Strategic Diagnostics, Inc.)
- Sensor-Kinesis Corporation
- Siemens Medical Solutions USA, Inc.
- Smiths Group Plc
- Sober Steering Sensors Canada, Inc.
- Sysmex Corporation
- Thermo Fisher Scientific, Inc.
- Vigene Biosciences, Inc.
For more information about this report visit https://www.researchandmarkets.com/research/tcns8w/biosensors_a
